Aprea Therapeutics, Inc. Common stock (APRE) News

Latest headlines that mention APRE, newest first · each headline opens the original publisher

APRE quote

Last price: $0.45
Day change: -13.27%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

APRE headlines

latest coverage

Investing.com 6d ago

Aprea at Pre-ESMO Virtual Panel Conference: wEE1 bet leans on safety

General T3APRE

Investing.com 1mo ago

Aprea Therapeutics reports patent portfolio of 58 patents

General T3APRE

Seeking Alpha 2mo ago

Aprea Therapeutics records second consecutive surge, jumping another 22%

General T2APRE

Seeking Alpha 2mo ago

Aprea Therapeutics GAAP EPS of -$0.07 beats by $0.16

Earnings T2APRE

Investing.com 2mo ago

Aprea Therapeutics plans Q4 2026 data update for APR-1051 trial

General T3APRE

Seeking Alpha 5mo ago

Aprea Therapeutics GAAP EPS of -$0.22 beats by $0.01

Earnings T2APRE

APRE news alerts

Get an alert by email or push when a new headline mentions APRE.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.